Nasus Pharma stock reiterated at Market Outperform by Citizens

🌐 Investing.com (Cyprus) —
Nasus Pharma stock reiterated at Market Outperform by Citizens

AI Summary

Citizens has reiterated its Market Outperform rating on Nasus Pharma stock. The article provides no further details on the rationale or any change to its price outlook.

Markets Nasus Pharma Citizens stock rating Market Outperform equities

Read original source →